Orthopedic considerations in Gaucher disease since the advent of enzyme replacement therapy

Acta Orthopaedica Scandinavica

Volumn 75, Issue 6, 2004, Pages 641-653

  Itzchaki, Menachem ^a   Lebel, Ehud ^a   Dweck, Altoon ^a   Patlas, Michael ^a   Hadas Halpern, Irith ^a   Zimran, Ari ^a   Elstein, Deborah ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADJUVANT THERAPY; ANALGESIA; ANTIBIOTIC THERAPY; ARTHROPLASTY; AVASCULAR NECROSIS; BONE DISEASE; BONE PAIN; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE SEVERITY; ENZYME REPLACEMENT; ENZYME THERAPY; GAUCHER DISEASE; GENOTYPE; HEPATOSPLENOMEGALY; HUMAN; HYPERSPLENISM; JOINT NECROSIS; LYSOSOME STORAGE DISEASE; MEDICAL LITERATURE; META ANALYSIS; MORBIDITY; NEUROLOGIC DISEASE; ONSET AGE; PATHOLOGIC FRACTURE; PATIENT MONITORING; POSTOPERATIVE PAIN; PREVALENCE; REVIEW; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; BONE AND BONES; BONE DENSITY; BONE DISEASES; CHILD; CHILD, PRESCHOOL; ENZYMES; FEMALE; GAUCHER DISEASE; HUMANS; MALE; ORTHOPEDIC PROCEDURES;

EID: 10944264657     PISSN: 00016470     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016470410004003     Document Type: Review

References (71)

1. Abrahamov A, Elstein D, Gross-Tsur V, Farber B, Glaser Y, Hadas-Halpern I, Ronen S, Tafakjdi M, Horowitz M, Zimran A. Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype. Lancet 1995; 346 (8981):1000-3.
2. Aharoni D, Mekhmandarov S, Itzchaki M, Hiller N, Elstein D. Avascular necrosis of the sacroiliac joint in a patient with Gaucher disease. Isr Med Assoc J 2001; 3 (10): 767-8.
3. Aharoni D, Krausz Y, Elstein D, Hadas-Halpern I, Zimran A. Tc-99m sestamibi bone marrow scintigraphy in Gaucher disease. Clin Nucl Med 2002; 27 (7): 503-9.
4. Alkalai I, Kaufmann J, Shazar Y. (Bilateral total hip replacement in a young woman with Gaucher disease). Harefuah 1979; 96 (8): 480-1.
5. Allison J W, James C A, Arnold G L, Stine K C, Becton D L, Bell J M. Reconversion of bone marrow in Gaucher disease treated with enzyme therapy documented by MR. Pediatr Radiol 1998; 28 (4): 237-40.
6. Altarescu G, Hill S, Wiggs E, Jeffries N, Kreps C, Parker C C, Brady R O, Barton N W, Schiffmann R. The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease. J Pediatr 2001; 138 (4): 539-47.
7. Barton N W, Brady R O, Dambrosia J M, Di Bisceglie A M, Doppelt S H, Hill S C, Mankin H J, Murray G J, Parker R I, Argoff C E, et al. Replacement therapy for inherited enzyme deficiency: macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med 1991; 324: 1464-70.
8. Beighton P, Goldblatt J, Sacks S. Bone involvement in Gaucher disease. In: Gaucher disease: A century of delineation and research (eds. Desnick R J, Gatt S, Grabowski G A). 1982: 107-29. Alan R Liss: New York.
9. Beutler E. Case 20-2003: Gaucher's disease. N Engl J Med 2004; 350: 416-7.
10. Beutler E, Grabowski G A. Gaucher disease. In: The Metabolic and molecular bases of inherited diseases (eds. Scriver C R, Valle D, Beudet A, Sly W S) Vol III. 2001: 3635-68. McGraw-Hill. New York.
11. Bisagni-Faure A, Dupont A M, Chazerain P, Job-Deslandre C, Chevrot A, Menkes C J. Magnetic resonance imaging assessment of sacroiliac joint involvement in Gaucher's disease. J Rheumatol 1992; 19 (12): 1984-7.
12. Carter L C, Fischman S L, Mann J, Elstein D, Stabholz A, Zimran A. The nature and extent of jaw involvement in Gaucher disease: observations in a series of 28 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85 (2): 233-9.
13. Castronovo F P Jr, McKusick K A, Doppelt S H, Barton N W. Radiopharmacology of inhaled 133Xe in skeletal sites containing deposits of Gaucher cells. Nucl Med Biol 1993; 20 (5): 707-14.
14. Charrow J, Esplin J A, Gribble T J, Kaplan P, Kolodny E H, Pastores G M, Scott C R, Wappner R S, Weinreb N J, Wisch J S. Gaucher disease: recommendations on diagnosis, evaluation, and monitoring. Arch Intern Med 1998; 158: 1754-60.
15. Charrow J, Andersson H C, Kaplan P, Kolodny E H, Mistry P, Pastores G, Rosenbloom B E, Scott C R, Wappner R S, Weinreb N J, Zimran A. The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med 2000; 160: 2835-43.
16. Ciana G, Cuttini M, Bembi B. Short-term effects of pamidronate in patients with Gaucher's disease and severe skeletal involvement. N Engl J Med 1997; 337 (10): 712.
17. Cohen I J, Katz K, Kornreich L, Horev G, Frish A, Zaizov R. Low-dose high-frequency enzyme replacement therapy prevents fractures without complete suppression of painful bone crises in patients with severe juvenile onset type I Gaucher disease. Blood Cells Mol Dis 1998; 24 (3): 296-302.
18. Cremin B J, Davey H, Goldblatt J. Skeletal complications of type I Gaucher disease: the magnetic resonance features. Clin Radiol 1990; 41 (4): 244-7.
19. Drugan C, Jebeleanu G, Grigorescu-Sido P, Caillaud C, Craciun A M. Biochemical markers of bone turnover as tools in the evaluation of skeletal involvement in patients with type 1 Gaucher disease. Blood Cells Mol Dis 2002; 28 (1): 13-20.
20. Elstein D, Hadas-Halpern I, Itzchaki M, Lahad A, Abrahamov A, Zimran A. Effect of low-dose enzyme replacement therapy on bones in Gaucher disease patients with severe skeletal involvement. Blood Cells Mol Dis 1996; 22 (2): 104-11.
21. Elstein D, Itzchaki M, Mankin H J. Skeletal involvement in Gaucher disease. In: Bailliere's Clinical haematology. Harcourt brace (ed Zimran A) 1997; 10: 793-816.
22. Elstein D, Abrahamov A, Itzchaki M, Zimran A. Commentary: Low-dose high-frequency enzyme replacement therapy prevents fractures without complete suppression of painful bone crises in patients with severe juvenile onset type I Gaucher disease. Blood Cells Mol Dis 1998; 24: 303-5.
23. Fleshner P R, Aufses A H Jr, Grabowski G A, Elias R. A 27-year experience with splenectomy for Gaucher's disease. Am J Surg. 1991; 161 (1): 69-75.
24. Gillis S, Hyam E, Abrahamov A, Elstein D, Zimran A. Platelet function abnormalities in Gaucher disease patients. Am J Hematol 1999; 61: 103-6.
25. Goldblatt J, Sacks S, Dall D, Beighton P. Total hip arthroplasty in Gaucher's disease. Long-term prognosis. Clin Orthop 1988; (228): 94-8.
26. Grabowski G A, Horowitz M, Gaucher's disease: molecular, genetic and enzymological aspects. Baillieres Clin Haematol 1997; 10 (4): 635-56.
27. Hermann G, Goldblatt J, Levy R N, Goldsmith S J, Desnick R J, Grabowski G A. Gaucher's disease type 1: assessment of bone involvement by CT and scintigraphy. AJR Am J Roentgenol 1986; 147 (5): 943-8.
28. Hermann G, Shapiro R, Abdelwahab I F, Klein M J, Pastores G, Grabowski G. Extraosseous extension of Gaucher cell deposits mimicking malignancy. Skeletal Radiol 1994; 23 (4): 253-6.
29. Hill S C, Parker C C, Brady R O. MRI of multiple platyspondyly in Gaucher Disease: response to enzyme replacement therapy. J Comp Ass Tomog 1993; 17: 806-9.
30. Hollak C, Maas M, Akkerman E, den Heeten A, Aerts H. Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease. Blood Cells Mol Dis 2001; 27 (6): 1005-12.
31. Horev G, Kornreich L, Hadar H, Katz K. Hemorrhage associated with "bone crisis" in Gaucher's disease identified by magnetic resonance imaging. Skeletal Radiol 1991; 20 (7): 479-82.
32. Ida H, Rennert O M, Kato S, Ueda T, Oishi K, Maekawa K, Eto Y. Severe skeletal complications in Japanese patients with type 1 Gaucher disease. J Inherit Metab Dis 1999; 22 (1): 63-73.
33. Jmoudiak M, Itzchaki M, Hadas-Halpern I, Hrebicek M, Hodanova K, Elstein D, Zimran A. Iliopsoas hematoma in a young patient with type I Gaucher disease. Isr Med Assoc J 2003; 5 (9): 673-4.
34. Johnson L A, Hoppel B E, Gerard E L, Miller S P, Doppelt S H, Zirzow G C, Rosenthal D I, Dambrosia J M, Hill S C, Brady R O, et al. Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease. Radiology 1992; 182 (2): 451-5.
35. Katz K, Horev G, Rivlin E, Kornreich L, Cohen I J, Gruenbaum M, Yosipovitch Z. Upper limb involvement in patients with Gaucher's disease. J Hand Surg Am 1993a; 18 (5): 871-5.
36. Katz K, Sabato S, Horev G, Cohen I J, Yosipovitch Z. Spinal involvement in children and adolescents with Gaucher disease. Spine 1993b; 18 (3): 332-5.
37. Katz K, Kornreich L, Horev G, Ziv N, Soudry M, Cohen I J. Involvement of the foot and ankle in patients with Gaucher disease. Foot Ankle Int 1999; 20 (2): 104-7.
38. Kocher M S, Hall J E. Surgical management of spinal involvement in children and adolescents with Gaucher's disease. J Pediatr Orthop 2000; 20 (3): 383-8.
39. Kolodny E H, Ullman M D, Mankin H J, Raghavan S S, Topol J, Sullivan J L. Phenotypic manifestations of Gaucher disease: Clinical features in 48 biochemically verified type I patients and comment on type II patients. In: Gaucher disease: A century of delineation and research (eds. Desnick R J, Gatt S, Grabowski G A) 1982: 33-65. Alan R Liss, New York.
40. Larsen E C, Connolly S A, Rosenberg A E. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20-2003. A nine-year-old girl with hepatosplenomegaly and pain in the thigh. N Engl J Med 2003; 348: 2669-77.
41. Lebel E, Itzchaki M, Hadas-Halpern I, Zimran A, Elstein D. Outcome of total hip arthroplasty in patients with Gaucher disease. J Arthroplasty 2001; 16 (1): 7-12.
42. Lebel E, Elstein D, Hain D, Hadas-Halpern I, Zimran A, Itzchaki M. Osteonecrosis in a patient with Gaucher's disease treated with enzyme replacement. Isr Med Assoc J 2003; 5 (8): 595-6.
43. Maas M, Hollak C E, Akkerman E M, Aerts J M, Stoker J, Den Heeten G J. Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter. AJR Am J Roentgenol 2002; 179 (4): 961-5.
44. Mariani G, Filocamo M, Giona F, Villa G, Amendola A, Erba P, Buffoni F, Copello F, Pierini A, Minichilli F, Gatti R, Brady R O. Severity of bone marrow involvement in patients with Gaucher's disease evaluated by scintigraphy with 99mTc-sestamibi. J Nucl Med 2003; 44 (8): 1253-62.
45. Matoth Y, Fried K. Chronic Gaucher's disease. Clinical observations on 34 patients. Isr J Med Sci 1965; 1: 521-30.
46. Myers H S, Cremin B J, Beighton P, Sacks S. Chronic Gaucher's disease: radiological findings in 17 South African cases. Br J Radiol 1975; 48 (570): 465-9.
47. Noyes F R, Smith W S. Bone crises and chronic osteomyelitis in Gaucher's disease. Clin Orthop 1971; (79): 132-40.
48. Pastores G M, Einhom T A. Skeletal complications of Gaucher disease: pathophysiology, evaluation, and treatment. Sem Hemat 1995; 32: 20-7.
49. Pastores G M, Wallenstein S, Desnick R J, Luckey M M. Bone density in Type I Gaucher disease. J Bone Miner Res 1996; 11 (11): 1801-7.
50. Poll L W, Koch J A, vom Dahl S, Loxtermann E, Sarbia M, Niederau C, Haussinger D, Modder U. Extraosseous manifestation of Gaucher's disease type 1: MR and histological appearance. Eur Radiol 2000; 10 (10): 1660-3.
51. Poll L W, Koch J A, vom Dahl S, Willers R, Scherer A, Boemer D, Niederau C, Haussinger D, Modder U. Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results. Skeletal Radiol 2001; 30 (9): 496-503.
52. Poll L W, Maas M, Terk M R, Roca-Espiau M, Bembi B, Ciana G, Weinreb N J. Response of Gaucher bone disease to enzyme replacement therapy. Br J Radiol (Suppl 1) 2002; 75: A25-36.
53. Rose J S, Grabowski G A, Barnett S H, Desnick R J. Accelerated skeletal deterioration after splenectomy in Gaucher type 1 disease. AJR Am J Roentgenol 1982; 139 (6): 1202-4.
54. Rosenthal D I, Mayo-Smith W, Goodsitt M M, Doppelt S, Mankin H J. Bone and bone marrow changes in Gaucher disease: evaluation with quantitative CT. Radiology 1989;170 (1 Pt 1): 143-6.
55. Rosenthal D I, Doppelt S H, Mankin H J, Dambrosia J M, Xavier R J, McKusick K A, Rosen B R, Baker J, Niklason L T, Hill S C, et al. Enzyme replacement therapy for glucocerebrosidase. Pediatrics 1995; 96: 629-37.
56. Ruff M E, Weis L D, Kean J R. Acute thoracic kyphosis in Gaucher's disease. A case report. Spine 1984; 9 (8): 835-7.
57. Samuel R, Katz K, Papapoulos S E, Yosipovitch Z, Zaizov R, Liberman U A. Aminohydroxy propylidene bisphosphonate (APD) treatment improves the clinical skeletal manifestations of Gaucher's disease. Pediatrics 1994; 94 (3): 385-9.
58. Schappert S M. Office visits to orthopedic surgeons: United States, 1995-96. Adv Data 1998; 302: 1-32.
59. Schein A J, Arkin A M. The classic: hip-joint involvement in Gaucher's disease. Clin Orthop 1973; (90): 4-10.
60. Schiffmann R, Mankin H, Dambrosia J M, Xavier R J, Kreps C, Hill S C, Barton N W, Rosenthal D I. Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapy. Blood Cells Mol Dis 2002; 28 (2): 288-96.
61. Schwartz A M, Homer M J, McCauley R G. "Step-off" vertebral body: Gaucher's disease versus sickle cell hemoglobinopathy. AJR Am J Roentgenol 1979; 132 (1): 81-5.
62. Sidransky E, Ginns E I, Westman J A, Ehmann W C. Pathologic fractures may develop in Gaucher patients receiving enzyme replacement therapy. Am J Hematol 1994; 47 (3): 247-9.
63. Svennerholm L, Dreborg S, Erikson A, et al. Gaucher disease of the Norbottnian (type III). Phenotypic manifestations. In: Gaucher disease: A century of delineation and research (eds. Desnick R J, Gatt S, Grabowski GA) 1982: 67-94. Alan R Liss, New York.
64. Tauber C, Tauber T. Gaucher disease - the orthopaedic aspect. Report of seven cases. Arch Orthop Trauma Surg 1995; 114 (3): 179-82.
65. van Wellen P A, Haentjens P, Frecourt N, Opdecam P. Loosening of a noncemented porous-coated anatomic femoral component in Gaucher's disease. A case report and review of literature. Acta Orthop Belg 1994; 60 (1): 119-23.
66. Weigler J M, Seldin R, Minkowitz S. Gaucher's disease involving the mandible: report of case. J Oral Surg 1967; 25 (2): 158-63.
67. Weinreb N J, Charrow J, Andersson H C, Kaplan P, Kolodny E H, Mistry P, Pastores G, Rosenbloom B E, Scott C R, Wappner R S, Zimran A. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Am J Med 2002; 113: 112-9.
68. Yossipovitch Z H, Herman G, Makin M. Aseptic osteomyelitis in Gaucher's disease. Isr J Med Sci 1965; 1 (4): 531-6.
69. Zanzi I, Taylor S, Gould E, Allen S L, Kroop S, Asnis S, Margouleff D. Scintigraphic and magnetic resonance studies in a patient with Gaucher's disease. Clin Nucl Med 1988; 13 (7): 491-5.
70. Zimran A, Kay A, Gelbart T, Garver P, Thurston D, Saven A, Beutler E. Gaucher disease. Clinical, laboratory, radiologic and genetic features of 53 patients. Medicine 1992; 71: 337-53.
71. Zimran A, Elstein D, Schiffmann R, Abrahamov A, Goldberg M, Bar-Maor J A, Brady R O, Guzzetta P C, Barton N W. Outcome of partial splenectomy for type I Gaucher disease. J Pediatr 1995; 126 (4): 596-7.